{"filing":{"accession_number":"0001062993-26-004891","cik":"0002066836","ticker":"CNXU","company_name":"Conexeu Sciences Inc.","form":"8-K","filing_date":"2026-09-10","report_date":"2026-09-04","primary_document":"form8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326004891/form8k.htm"},"events":[{"id":32702,"run_id":30063,"accession_number":"0001062993-26-004891","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The disclosure details unregistered issuances of 1,448,368 common shares and 202,500 warrants from June 18 through September 4, 2026, which in aggregate exceeded 5% of outstanding shares, triggering Item 3.02 disclosure. These are private placements and warrant exercises relying on Regulation D and Regulation S exemptions, characteristic of dilutive equity issuances at small- to mid-cap companies raising capital through unregistered securities.","company_name":"Conexeu Sciences Inc.","ticker":"CNXU","filing_date":"2026-09-10","form":"8-K","submitted_at":null,"items":[{"id":35942,"accession_number":"0001062993-26-004891","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The disclosure details unregistered issuances of 1,448,368 common shares and 202,500 warrants from June 18 through September 4, 2026, which in aggregate exceeded 5% of outstanding shares, triggering Item 3.02 disclosure. These are private placements and warrant exercises relying on Regulation D and Regulation S exemptions, characteristic of dilutive equity issuances at small- to mid-cap companies raising capital through unregistered securities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:31:54.005603+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35942,"accession_number":"0001062993-26-004891","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The disclosure details unregistered issuances of 1,448,368 common shares and 202,500 warrants from June 18 through September 4, 2026, which in aggregate exceeded 5% of outstanding shares, triggering Item 3.02 disclosure. These are private placements and warrant exercises relying on Regulation D and Regulation S exemptions, characteristic of dilutive equity issuances at small- to mid-cap companies raising capital through unregistered securities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:31:54.005603+00:00","company_name":"Conexeu Sciences Inc.","ticker":"CNXU","filing_date":"2026-09-10"}]}